Microtubule assembly and disassembly is required for the maintenance of cell structure, mobility, and division. However, the cellular and biochemical implications of microtubule disruption are not fully understood. Using a proteomic approach, we found that the peptidyl-prolyl isomerase, cyclophilin A, was increased in plasma membrane extracts from chronic myeloid leukemia cells after microtubule disruption. In addition, we found that two peptidyl-prolyl isomerases, cyclophilin A and pin1, are overexpressed up to 10-fold in hematological malignancies compared with normal peripheral blood mononuclear cells. Although previous reports suggest that cyclophilin A is localized to the cytosol of mammalian cells, we found that cyclophilin A and pin1 are both localized to the nucleus and nuclear domains in hematopoietic cells. Microtubule disruption of hematopoietic cells caused a dramatic subcellular redistribution of cyclophilin A and pin1 from the nucleus to the cytosol and plasma membrane. We suggest that this accounts for the increased cyclophilin A at the plasma membrane of chronic myeloid leukemia cells after microtubule disruption. The subcellular redistribution of cyclophilin A and pin1 occurred in a c-Jun NH 2 -terminal kinase-and serine protease-dependent manner. Moreover, the altered subcellular localization of the peptidyl-prolyl isomerases occurred in a dose-and time-dependent manner after microtubule disruption and was found to correlate with G 2 /M arrest and precede induced cell death. These results suggest that the function of peptidyl-prolyl isomerases may be influenced by microtubule dynamics throughout the cell cycle, and their altered localization may be an important part of the mechanism by which microtubuledisrupting agents exert their cytostatic effects.
2001), highlighting the need for alternative approaches and/or drug combinations for the treatment of cancer.
Microtubule dynamics play a crucial role in cytoskeletal structure, cell signaling, intracellular transport, cell polarity, and division (Mollinedo and Gajate, 2003) . The association of proteins with microtubules leads to their sequestration. Disruption of the microtubule network releases sequestered proteins, which can have critical consequences for cell fate and, therefore, represents an important therapeutic target that has been exploited in cancer chemotherapy (Zhou and Giannakakou, 2005; Bhat and Setaluri, 2007) . Microtubule-targeting agents have been successfully used for the treatment of cancer, where they act by suppressing microtubule dynamics and thereby microtubule function, thus leading to mitotic arrest and cell death. This has led to a search for new compounds targeted at microtubules that exhibit greater or comparable efficacy. We have reported previously the design, synthesis, and evaluation of pyrrolo-1,5-benzoxazepines, a novel series of microtubule-targeting agents that bind and depolymerize tubulin, leading to G 2 /M arrest and apoptosis in a variety of human tumors (Greene et al., 2005; Mulligan et al., 2006; Verma et al., 2008) . It was found recently that Gleevec enhanced the cell death induced by pyrrolobenzoxazepines and lead MTAs, paclitaxel and vinblastine, in CML cells (Greene et al., 2007) , highlighting the potential of MTAs in combination therapy regimens, which is an important approach to reduce the development of drug resistance. Although the mechanism of action of microtubule-targeting agents is suggested to be similar (Mollinedo and Gajate, 2003) , differential effects on MAP kinase signaling pathways has been reported (Stone and Chambers, 2000; Liu et al., 2001) . Investigation into the mechanism of action of the pyrrolobenzoxazepine PBOX-6 has revealed that early activation of the c-Jun NH 2 -terminal kinase (JNK) and a trypsin-like serine protease is essential for cell death (Mc Gee et al., 2002 McGrath et al., 2006) . However, many aspects of the molecular mechanism of PBOX-6 remain unknown, including details of the JNK-dependent signaling components. Uncovering upstream regulators of the signaling cascades induced by microtubule-targeting agents may uncover novel therapeutic targets.
Peptidyl-prolyl isomerases (PPIases) are a class of ubiquitously expressed proteins that comprise the parvulins, cyclophilins, FK506-binding proteins, and the recently identified Ser/Thr phosphatase two A phosphatase activator (Table 1 ) (Wang and Heitman, 2005; Jordens et al., 2006; Lu et al., 2007) . The primary function of PPIases is to catalyze the cis-trans isomerization of peptide bonds located at the N terminus of proline residues in polypeptide chains. As such, they are thought to play a role during protein folding and transport; however, their precise cellular function is not fully understood. The best characterized PPIase is the parvulin pin1, which is overexpressed in human tumors (Bao et al., 2004) , where it regulates numerous oncogenic pathways 
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at ASPET Journals on May 1, 2017 jpet.aspetjournals.org (Shen et al., 1998; Wulf et al., 2001 ). This discovery raises new interest in the importance of prolyl cis-trans isomerization as a regulatory mechanism and as a new target for therapeutic intervention. Cyclophilin A has been found recently to be overexpressed in lung (Howard et al., 2005) and pancreatic (Li et al., 2006) cancer; however, its precise role during tumorigenesis remains unknown (Choi et al., 2007) . In this study, we conducted a proteomic screen for potential novel molecular targets of microtubule-targeting agents, the microtubule-depolymerizing agent, PBOX-6, and the microtubule-stabilizing agent, paclitaxel, in hematopoietic cells. We identified alterations in the protein component of the plasma membrane compartment after treatment with microtubule-targeting agents. Proteins that were differentially located at the plasma membrane after treatment with microtubule-targeting agents were identified by one dimensional SDS-PAGE followed by MALDI-TOF mass spectrometry and one was shown to be the PPIase, cyclophilin A (cypA). Expression and subcellular localization of PPIases in hematopoietic cells were investigated, and we report that altered localization of the PPIases after microtubule disruption correlates with the induction of G 2 /M arrest and may be an important part of the mechanism by which microtubuletargeting agents exert their effects.
Materials and Methods
Materials.
The pyrrolobenzoxazepine PBOX-6 was synthesized as described previously (Mc Gee et al., 2002) . Paclitaxel, N-tosyl-Lphenylalanine chloromethyl ketone (TPCK), and N-tosyl-L-lysine chloromethyl ketone (TLCK) were from Sigma Chemical (Poole, Dorset, UK). Anti-␤-actin primary antibody, anti-mouse, and anti-rabbit horseradish peroxidase-conjugated secondary antibodies were obtained from Sigma Chemical. CEP-11004 (Ciallella et al., 2005) was obtained from Cephalon Inc. (West Chester, PA). Anti-cypA primary antibody was from Millipore (Billerica, MA), and anti-pin1 primary antibody was from Calbiochem (San Diego, CA). PlusOne silver staining kit and the ECL detection kit were obtained from GE Healthcare (Chalfont St. Giles, UK).
Cell Culture. CML cell lines (K562, LAMA 84, and KYO.1) were received from Professor Mark Lawler (Institute of Molecular Medicine, Trinity College Dublin and St. James's Hospital, Dublin, Ireland). HL-60 promyelocytic leukemia, Jurkat T-lymphoma, and H1299 cells were obtained from the European Collection of Cell Cultures (Porton Down, Wiltshire, UK). CML, Jurkat, and H1299 cells were cultured in RPMI medium supplemented with 10% FCS, 2 mM L-glutamine, 100 g/ml penicillin, and 100 g/ml streptomycin. HL-60 cells were cultured in RPMI medium containing 20% FCS. HeLa cells were grown in minimum essential medium supplemented with 10% FCS, 2 mM L-glutamine, 100 g/ml penicillin, and 100 g/ml streptomycin. All cells were maintained at 37°C.
Flow Cytometric Analysis. Cells were harvested by centrifugation at 200g for 5 min and washed in 10 ml of ice-cold PBS. The cell pellet was resuspended in 200 l of PBS, and cells were fixed in 2 ml of ice-cold 70% ethanol at 4°C overnight. Cells were centrifuged at 200g for 5 min to remove the ethanol and resuspended in 400 l of PBS. RNase A (0.5 mg/ml) and propidium iodide (200 M) were added, and samples were incubated in the dark at 37°C for 30 min. Cell cycle profiles were analyzed on a Coulter Flow Cytometer using the XL SYSTEM II software (Beckman Coulter, Fullerton, CA).
Preparation of Plasma Membrane Extracts. A plasma membrane fraction was isolated after subcellular fractionation of mammalian cells, as outlined by Boone et al. (1969) , with minor modifications. In brief, cells were harvested by centrifugation at 200g for 5 min followed by washing in ice-cold PBS. Cells were lysed with 20 mM Tris/Cl, pH 7.4, 10 mM EDTA, 5 mM EGTA supplemented with 5 mM dithiothreitol, 10 mM benzamidine, 10 g/ml leupeptin, 50 g/ml phenylmethylsulfonyl fluoride, 0.1 g/ml ovalbumin, and 4 g/ml aprotinin. Samples were incubated on ice for 15 min, followed by passage 30 times through a 21-gauge needle followed by vigorous vortexing for 2 min. Cells were incubated on ice for 15 min, and the homogenates were centrifuged at 200g for 10 min at 4°C to remove nuclei, unbroken cells, and cellular debris. The supernatant was removed and centrifuged at 1200g for 10 min at 4°C. The pellet containing plasma membranes was resuspended in 20 mM Tris/Cl, pH 7.4, 10 mM EDTA, 5 mM EGTA, and 1% Nonidet P-40 supplemented with 5 mM dithiothreitol, 10 mM benzamidine, 10 g/ml leupeptin, 50 g/ml phenylmethylsulfonyl fluoride, 0.1 g/ml ovalbumin, and 4 g/ml aprotinin, sonicated for 10 s to reduce viscosity, and stored at Ϫ20°C.
SDS-PAGE and Silver Staining of Proteins. Protein (30 g) was separated by 10% SDS-PAGE. After electrophoresis, the gels were incubated in fixing solution [10% (v/v) Destaining and Tryptic Digest of Silver-Stained Proteins. Silver stained gels were washed 2 ϫ 10 min in distilled H 2 O, and gel pieces containing the protein were excised. For tryptic digestion, gel pieces were washed in acetonitrile (ACN). Equal volumes of potassium ferricyanide (30 mM) and sodium thiosulfate (100 mM) were used to destain the gel pieces at room temperature, with occasional mixing until the brown color disappeared. The gel pieces were then washed a further 3 ϫ 5 min in distilled H 2 O and incubated in 70 l of NH 4 HCO 3 (200 mM), pH 7.8, for 20 min at 37°C with shaking. The NH 4 HCO 3 was removed, and 70 l of NH 4 HCO 3 (200 mM)/ACN (2:3) was added to each tube and shaken for 10 min at 37°C, followed by removal as before. Seventy microliters of NH 4 HCO 3 (50 mM) was added to each tube and incubated for 10 min at 37°C with gentle rocking. The solution was removed, and the gel was incubated with 10 mM dithiothreitol and 100 mM NH 4 HCO 3 and shaken for 1 h at 56°C before removal as before. Fifty microliters of 50 mM iodoacetamide in 100 mM NH 4 HCO 3 was added and incubated for 30 min at room temperature in the dark. This solution was removed and replaced with 300 l of NH 4 HCO 3 (100 mM)/ACN (1:1) for 15 min at 37°C. This solution was removed, and 100 l of ACN was added for 10 min at 37°C before removal as before. Trypsin was added, and samples were incubated at 37°C overnight with continuous shaking. The solution was removed, and 50 l of ACN (60%)/TFA (0.2%) was added and incubated for 10 min at 37°C. Finally, sample volume was reduced in a vacuum centrifuge.
Peptide Mass Fingerprinting. Analysis of the peptides produced from the tryptic digestions was performed on an Applied Biosystems 4700 MALDI-TOF mass spectrometer (Applied Biosystems, Foster City, CA), using 10 mg/ml ␣-cyano-4-hydroxycinnamic acid as the matrix, and mass spectra were acquired in the reflector mode. The precursor ion masses were searched using Mascot Search software (http://www.matrixscience.com) incorporated in GPS Explorer version 3.5 software. The UniProt SwissProt nonredundant database and human taxonomy were used for all searches. Methionine oxidation and cysteine carboxyamidomethylation were specified as variable modifications, and a maximum of one missed cleavage site was allowed.
Isolation of Peripheral Blood Mononuclear Cells. Whole blood (50 ml) was collected from normal healthy donors in heparin-ized tubes (Vacutainer; BD Biosciences, San Jose, CA) and was mixed 1:1 with Hanks' balanced salt solution containing phenol red and layered carefully over 30 ml of Lymphoprep before centrifugation at 200g for 25 min at room temperature. The interface layer, which comprises the peripheral blood mononuclear cells (PBMCs), was collected, washed twice in Hanks' balanced salt solution, and resuspended in RPMI medium supplemented with 10% (v/v) FCS, 2 mM L-glutamine, 50 g/ml penicillin, and 50 g/ml streptomycin.
Preparation of Whole-Cell Extracts. Cells were harvested by centrifugation at 200g for 5 min followed by washing in ice-cold PBS. The cell pellets were resuspended in 600 mM urea, 8 mM Tris/Cl, 100 mM glycerol, 20 nM bromphenol blue, and 5% ␤-mercaptoethanol, incubated on ice for 10 min, and extracts were sonicated to reduce viscosity.
Immunoblot Analysis. An equal amount of protein (30 g) was separated by SDS-PAGE (15%), and proteins were transferred onto polyvinylidene difluoride membranes (Sigma Chemical) using the Mini-Protean II blotting system. Membranes were blocked overnight at 4°C in 5% nonfat dry milk in TBS (10 mM Tris/Cl, 150 mM NaCl). Membranes were washed in TBST (TBS containing 0.05% Tween 20) for 2 min and incubated with anti-cypA antibody or anti-pin1 primary antibodies diluted 1:1000 in TBS containing 1% dry milk for 1 h at room temperature. After incubation, membranes were washed for 30 min in TBST and incubated with goat anti-rabbit horseradish peroxidase-coupled secondary antibody diluted 1:1000 in TBS containing 1% (w/v) dry milk for 1 h at room temperature. Membranes were then washed for 30 min in TBST before development using an ECL detection kit according to the manufacturer's instructions.
Immunofluorescence. An aliquot of cells (150 l) was cytocentrifuged onto glass slides at 150g for 2 min using a Shandon Cytospin 2 (Thermo Fisher Scientific, Waltham, MA). Cells were fixed with 3% paraformaldehyde in PBS for 30 min at room temperature and gently washed in PBS. Cells were then placed in 50 mM NH 4 Cl for 5 min before permeabilization in 0.1% Triton X-100 in PBS for 3 min at room temperature. After washing in PBS, the cells were blocked in 2% BSA for 30 min, washed in PBS, and incubated with either anti-cypA antibody (1:50 dilution) or anti-pin1 antibody (1:10 dilution) in a humidity chamber for 1 h at room temperature. After washing in PBS, the cells were incubated with either anti-rabbit Alexa Fluor 594 or 488 antibodies (1:200 dilution), respectively (Invitrogen, Carlsbad, CA) for 1 h at room temperature in the dark. Nuclei were stained with DAPI (1 g/ml) for 20 s. Coverslips were fixed to the slides using DakoCytomation fluorescent mounting medium (Dako North America, Inc., Carpinteria, CA). Stained cells were visualized using a Leica DMLB microscope (Leica, Wetzlar, Germany), and images were captured using the Axiocam system and Axiovision 3.0.6 software (Carl Zeiss Inc., Thornwood, NY).
Results
Identification of Elevated Levels of CypA in Plasma
Membrane Extracts from CML Cells after Microtubule Disruption. Subcellular fractionation was used to isolate plasma membrane extracts from K562 cells after treatment with PBOX-6 (10 M) and paclitaxel (1 M) for 45 min. Isolated proteins were resolved by SDS-PAGE and silver stained. Comparison of the protein fractions isolated from control and treated cells showed several changes, but the most markedly elevated levels of a protein band of approximately 16 kDa were after treatment of cells with either PBOX-6 or paclitaxel (Fig. 1A) . The target protein was excised from the gels, subjected to tryptic digestion and analyzed by MALDI-TOF mass spectrometry. Resulting peptides were searched against the SwissProt database, and the protein was identified as human cyclophilin A, accession number P05092. Results highlight a significant Mascot probability A, K562 cells (5 ϫ 10 6 ) were treated with either vehicle (1% ethanol), PBOX-6 (10 M), or paclitaxel (1 M) for 45 min. Plasma membrane extracts were prepared, and protein (30 g) was separated by SDS-PAGE (12%) and silver stained. Proteins that were differentially located in the plasma membrane extracts after treatment with PBOX-6 or paclitaxel are highlighted by the arrow. B and C, amino acid sequence of protein excised from PBOX-6 (B)-and paclitaxel (C)-treated cells was identified as human cyclophilin A. Peptides directly identified via mass spectrometry using the Mascot search engine are underlined. Mascot search tool identified ions as a fragment of human cyclophilin A with a probability-based mouse score of 60 and 64 for PBOX-6 and paclitaxel, respectively.
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CypA and Pin1 Are Overexpressed in CML Cells. In addition to cypA, which is overexpressed in nonsmall lung cancer and pancreatic tumors (Howard et al., 2005; Li et al., 2006) a second PPIase, pin1, is overexpressed in a variety of solid human tumors, including breast and prostate (Bao et al., 2004) , implicating a role during tumor development. So far, a direct comparison of the expression levels of either cypA or pin1 in normal and malignant hematopoietic cells has not been performed. We examined levels of cypA and pin1 in normal PBMCs from healthy volunteers and in three CML cell lines, KYO.1, LAMA 84, and K562, which represent the three stages of CML progression from chronic, accelerated, and blast crises, respectively. Results from Western blot indicate that cypA and pin1 are overexpressed in the three hematopoietic cell lines, KYO.1, LAMA 84, and K562, compared with normal PBMCs, which is representative of PBMCs isolated from four healthy donors (Fig. 2, A and B) . Densitometry was used to quantify protein levels in normal PBMCs and CML cells and indicated that levels of cypA were increased by 10-, 4.5-, and 4-fold in KYO.1, LAMA 84, and K562 cells, respectively (Fig. 2C) . In addition, levels of pin1 were increased by 9-, 9-, and 8-fold in KYO.1, LAMA 84, and K562 cells, respectively (Fig. 2C) . These results suggest that in addition to their role in solid tumors previously described, cypA and pin1 may play a role in tumorigenesis of diffuse tumors such as CML.
CypA Undergoes Nucleocytoplasmic Redistribution after Microtubule Disruption of CML Cells. Using Western blot analysis of whole-cell extracts from synchronized K562 cells, it was found that levels of cypA in K562 cells are not altered through the cell cycle or after treatment with PBOX-6 or paclitaxel for up to 24 h (data not shown). Therefore, the subcellular localization of cypA was examined in K562 cells. Cells were treated with vehicle (1% ethanol), PBOX-6 (10 M), or paclitaxel (1 M) for 16 h and immunostained. Control cells, which were treated with vehicle for 16 h, illustrate that cypA is located predominantly in the nucleus and the nuclear periphery (Fig. 3A) . In contrast, treatment of cells with PBOX-6 or paclitaxel induced the redistribution of cypA from the nucleus to the cytosol of the cell.
Pin1 Undergoes Nucleocytoplasmic Redistribution after Microtubule Disruption of CML Cells. Western blot analysis of whole-cell extracts from synchronized cells demonstrated that total cellular levels of pin1 were unaltered in K562 cells through the cell cycle or after treatment with PBOX-6 or paclitaxel for up to 24 h (data not shown). However, in a manner similar to that observed with cypA, pin1 undergoes nucleocytoplasmic redistribution after treatment with microtubule-targeting agents. Results, shown in Fig.  3B , illustrate that pin1 is predominantly located in the nucleus and the nuclear periphery of control K562 cells, which were treated with vehicle for 16 h. However, treatment of cells with PBOX-6 or paclitaxel for 16 h induced the redistribution of pin1 from the nucleus to the cytosol of the cell.
CypA and Pin1 Undergo Nucleocytoplasmic Redistribution in Solid and Diffuse Tumor Cells after Microtubule Disruption. To date, the role of cypA and pin1 in tumorigenesis is not completely understood, and the subcellular location may provide important insights into a possible function. Therefore, we examined the subcellular distribution of cypA and pin1 in a variety of leukemia and lymphoma cells and solid tumor cells before and after microtubule disruption. Cells were treated with vehicle, PBOX-6 (10 M), or paclitaxel (1 M) for 16 h, and the subcellular location of cypA and pin1 was analyzed by fluorescence microscopy. As shown in Fig. 4 , A and B, cypA and pin1 are predominantly localized to the nucleus in the KYO.1, LAMA 84, Jurkat T-lymphoma, and HL-60 promyelocytic leukemia cells and undergo nucleocytoplasmic redistribution after treatment with PBOX-6 and paclitaxel. Approximately 40% of cells contained cytoplasmic cypA and pin1 after treatment of MTAs, which correlated with the extent of G 2 /M arrest induced (data not shown). However, in contrast to the leukemia and lymphoma cells tested, cypA and pin1 reside in both the nucleus and cytoplasm of the HeLa cervical cancer cells and H1299 non-small cell lung carcinoma cells, and treatment of HeLa and H1299 cells with PBOX-6 and paclitaxel leads to reduced cypA and pin1 staining in the nucleus, with a concomitant increase in cytoplasmic staining of cypA. CypA and pin1 are overexpressed in chronic myeloid leukemia cells. Whole-cell protein extracts were prepared from normal PBMCs and from KYO.1, LAMA 84, and K562 cells. Protein (30 g) was resolved by SDS-PAGE and transferred onto polyvinylidene difluoride blotting membrane. Membranes were probed with anti-cypA (A) or anti-pin1 (B) primary antibodies followed by an anti-rabbit secondary antibody, and protein was visualized by ECL. Membranes were stripped and reprobed with ␤-actin as a loading control. C, densitometric scanning of membranes using a Canon CanoScan LiDE 60 and Image J software was used to quantify protein levels. Protein levels were normalized using ␤-actin. Low protein level in the PBMCs was assigned an arbitrary value of 1, and protein levels in KYO.1, LAMA 84, and K562 cells were expressed as -fold increase.
PBOX-6-Induced Redistribution of CypA and Pin1
Occurs through a JNK-Dependent Pathway. We previously have dissected components of PBOX-6 signaling in K562 cells and have shown that activation of the JNK map kinase signaling pathway is essential for cell death induced by PBOX-6 (Mc Gee et al., 2002 . Therefore, the role of JNK during PBOX-6-induced redistribution of cypA and pin1 in K562 cells was investigated. JNK activity was inhibited by 5 ) were treated with vehicle, PBOX-6 (10 M), or paclitaxel (1 M) for 16 h. Cells were cytocentrifuged onto slides and fixed in 3% paraformaldehyde for 30 min followed by permeabilization in 0.1% Triton X-100 for 3 min. Cells were blocked in 2% BSA for 30 min and incubated with anti-cypA (A) or anti-pin1 (B) (1:100) antibody for 1 h before washing in PBS. Cells were incubated with Alexa Fluor 594 and Alexa Fluor 488 (1:200) to detect cypA (red) and pin1 (green), respectively. Nuclei were stained blue with DAPI (1 g/ml), and images were viewed by fluorescent microscopy. Fig. 3 . Subcellular redistribution of cypA and pin1 after microtubule disruption in K562 cells. Cells (3 ϫ 10 5 /ml) were treated with vehicle (1% ethanol) (Control), PBOX-6 (10 M), or paclitaxel (1 M) for 16 h. An aliquot (200 l) was cytocentrifuged onto slides and fixed in 3% paraformaldehyde for 30 min followed by permeabilization in 0.1% Triton X-100 for 3 min. Cells were blocked in 2% BSA for 30 min and incubated with anti-cypA (1:100) (A) and anti-pin1 (1:100) (B) antibodies for 1 h before washing in PBS. Cells were incubated with Alexa Fluor 594 and Alexa Fluor 488 (1:200) to detect cypA (red) and pin1 (green), respectively. Nuclei were stained blue with DAPI (1 g/ml) and viewed by fluorescent microscopy. Merged images are displayed (3 and 6).
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at ASPET Journals on May 1, 2017 jpet.aspetjournals.org Downloaded from treatment with the inhibitor, CEP-11004 (5 M), for 1 h before PBOX-6 (10 M) for 16 h. Cells were immunostained, and the subcellular localization of cypA and pin1 was examined by immunofluorescence. In vehicle-treated cells, cypA and pin1 are predominantly localized to the nucleus. Treatment with CEP-11004 alone for 1 h does not alter PPIase localization. Treatment of cells with PBOX-6 induced nucleocytoplasmic redistribution of the PPIases as previously shown. However, pretreatment of cells with CEP-11004 blocks PBOX-6-induced nucleocytoplasmic redistribution of cypA and pin1 (Fig. 5A) . These data suggest that PBOX-6-induced nucleocytoplasmic redistribution of cypA and pin1 occurs in a JNK-dependent manner in K562 cells, and it may be an integral part of the cell death mechanism of microtubule-disrupting agents.
PBOX-6-Induced Redistribution of CypA and Pin1 Occurs through a Trypsin-Like Serine Protease-Dependent Pathway. We previously reported that the trypsinlike serine protease inhibitor, TLCK, inhibits cell death induced by PBOX-6 in K562 cells, whereas the chymotrypsinlike serine protease inhibitor, TPCK, does not (McGrath et al., 2006) . To determine the involvement of serine proteases during PBOX-6-induced redistribution of cypA and pin1, K562 cells were pretreated with TLCK (200 M) or TPCK (20 M) for 1 h followed by PBOX-6 (10 M) treatment for 16 h. The subcellular localization of cypA and pin1 was determined by immunofluorescence. Treatment of cells with TPCK or TLCK alone did not alter cypA and pin1 localization. In agreement with earlier findings, cypA and pin1 underwent nucleocytoplasmic redistribution after treatment with PBOX-6 for 16 h (Fig. 5B) . However, pretreatment of cells with TLCK prevents PBOX-6-induced cypA and pin1 redistribution. In contrast to this, TPCK did not prevent PBOX-6-induced nucleocytoplasmic redistribution of cypA and pin1. These results suggest that the alterations to cypA and pin1 localization after PBOX-6 treatment are dependent on upstream activation of a trypsin-like serine protease in K562 cells.
Subcellular Redistribution of CypA and Pin1 Correlates with G 2 /M Arrest and Precedes Cell Death Induced after Microtubule Disruption in K562 Cells. In recent years, studies into the function of pin1 during tumorigenesis have suggested that it regulates a number of oncogenic pathways including cell proliferation and MAP kinase signaling (Shen et al., 1998; Wulf et al., 2001) . However, the role of cypA in tumor cells is poorly understood. In this study, we examined the timing of cypA and pin1 redistribution in hematopoietic cells. Asynchronous K562 cells were treated with PBOX-6 (10 M) or paclitaxel (1 M) for 1, 2, 4, 6, and 8 h or the outlined concentrations of PBOX-6 and paclitaxel. An aliquot of cells was immunostained for the detection of cypA or pin1 by immunofluorescence as previously described. The number of cells with cytoplasmic cypA or pin1 was determined by counting three fields of view with approximately 100 cells /view, and the percentage of cells with subcellular cypA or pin1 redistribution was calculated. Results show the dose-and time-dependent increase in cytoplasmic cypA and h. An aliquot (200 l) of each sample was cytocentrifuged onto slides and fixed in 3% paraformaldehyde for 30 min followed by permeabilization in 0.1% Triton X-100 for 3 min. Cells were blocked in 2% BSA for 30 min and incubated with anti-cypA (1:100) and anti-pin1 (1:100) antibodies for 1 h before washing in PBS. Cells were incubated with Alexa Fluor 594 and Alexa Fluor 488 (1:200) to detect cypA (red) and pin1 (green), respectively. Nuclei were stained blue with DAPI (1 g/ml) and viewed by fluorescent microscopy. pin1 in K562 cells after microtubule disruption using PBOX-6 (Fig. 6, A and B) and paclitaxel (Fig. 7, A and B) .
In parallel, cells were harvested at each time point, and the cell cycle profile was determined by measuring the DNA content after propidium iodine staining. The proportion of cells in the G 2 /M phase of the cell cycle was calculated. Results shown in Fig. 6, C and D, and Fig. 7, C and D,  indicate that approximately 25 to 30% of vehicle-treated cells are in the G 2 /M phase at each time point tested, which is consistent with an asynchronous cell population. PBOX-6 and paclitaxel induce a time-and dose-dependent accumulation of cells in G 2 /M, which increases to approximately 60% after 8 h (Figs. 6C and 7C, respectively) . The appearance of a pre-G 1 peak, which is indicative of cells undergoing apoptosis, is not apparent in K562 cells until after 24-h treatment with PBOX-6 (10 M) as previously published (Greene et al., 2008) or paclitaxel (1 M) (data not shown). Fluorescent examination of DAPI-stained cells confirmed that PBOX-6 and paclitaxel caused accumulation of cells arrested in metaphase, which are characterized by chromatin condensation and disruption of the nuclear envelope. Furthermore, from the images in Figs. 3 to 5, only metaphase-arrested cells display cytoplasmic cypA or pin1. These results suggest that the subcellular redistribution of cypA and pin1 in K562 cells occurs during mitosis, and levels correlate with metaphase arrest induced by microtubule-disrupting agents.
Discussion
Microtubules sequester important signaling molecules that may be released after microtubule alterations. For example, survivin and Bim are located on microtubules and participate in cell division and cell death (Li et al., 1998; Puthalakath et al., 1999) . Although microtubule-targeting agents have been used in cancer treatment for decades, their mechanism of action is not fully understood. It was shown that microtubule-targeting agents impair important aryl hydrocarbon receptor and glucocorticoid receptor (GR)-dependent functions (Vrzal et al., 2008) . Because drug transporters are under the transcriptional control of the GR, inhibition of GR-induced up-regulation of MDR expression may reverse the drug-resistant phenotype observed in many tumors and highlights an important mechanistic property of microtubuletargeting agents. In this study, we examined protein expression in subcellular compartments after microtubule disruption of CML cells using a tubulin-polymerizing agent, paclitaxel, and a recently described microtubule-depolymerizing agent, PBOX-6 (Mulligan et al., 2006) . We observed increased levels of an unidentified protein in the plasma membrane fraction of cells treated with paclitaxel and PBOX-6. In each case, the protein was identified as the human PPIase, cypA.
CypA is overexpressed in non-small cell lung cancer and pancreatic cancer (Howard et al., 2005; Li et al., 2006) ; however, its expression in hematopoietic malignancies has not been examined. We addressed this issue and examined the expression of two PPIases, cypA and pin1, in normal and malignant hematopoietic cells. We found that levels of cypA and pin1 are barely detectable in normal PBMCs isolated from healthy donors. However, in contrast, cypA and pin1 are overexpressed in a number of hematopoietic tumor cells including three CML cell lines. These findings implicate a role of cypA and pin1 in the development of hematological malignancies and are consistent with previous reports of their overexpression in solid tumors. For example, pin1 is overexpressed in 38 of 60 human tumors (Bao et al., 2004) . Although the study reported low levels of pin1 staining in lymphoma cells, expression was not compared directly with levels in corresponding normal cells.
Recently, it has been shown that cis-trans isomerization of the cypA substrate, Crk, regulates Crk-mediated signaling and emphasizes that in addition to pin1, cypA regulates important biological processes. In the current study, in situ fluorescent staining of cypA and pin1 has revealed that the two PPIases are predominantly localized to the nucleus and nuclear domains of CML cells. This finding is in contrast to solid tumors such as HeLa cervical carcinoma cells and H1299 nonsmall cell lung carcinoma, where cypA and pin1 are distributed throughout the cell, and Fig. 6 . Subcellular redistribution of cypA and pin1 after PBOX-6 treatment correlates with G 2 /M arrest in K562 cells. Cells (3 ϫ 10 6 ) were treated with either vehicle (1% ethanol) or PBOX-6 (10 M) for 1, 2, 4, 6, and 8 h (A) or 0.1, 1, 5, and 10 M PBOX-6 for 8 h (B). An aliquot of cells (200 l) was cytocentrifuged onto slides and fixed in 3% paraformaldehyde for 30 min, followed by permeabilization in 0.1% Triton X-100 for 3 min. Cells were blocked in 2% BSA for 30 min and incubated with anti-cypA or anti-pin1 antibody (1:100) for 1 h before washing in PBS. Cells were incubated with Alexa Fluor 594 and Alexa Fluor 488 (1:200) to detect cypA and pin1, respectively. Nuclei were stained blue with DAPI (1 g/ml) and viewed by fluorescent microscopy. Cells containing cytoplasmic cypA and pin1 were quantified by counting three fields of view with approximately 100 cells/view. C and D, cells were harvested by centrifugation and fixed in 70% ethanol overnight at 4°C. Cells were washed in PBS followed by the addition of RNase A (0.5 mg/ml) and propidium iodide (200 M), and samples were incubated at 37°C for 30 min. The percentage of cells in G 2 /M was determined by flow cytometry.
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at ASPET Journals on May 1, 2017 jpet.aspetjournals.org suggests that the location of pin1 and cypA is cell-type dependent, consistent with previous reports (Yeh and Means, 2007) . Although numerous studies report a nuclear and cytosolic location and, thus, function for pin1 in cancer cells, very little is known about the function of cypA. To our knowledge, this is the first report of a nuclear localization of cypA and pin1 in hematological malignancies and suggests a nuclear function in hematopoietic cells. This observation supports the hypothesis that the precise function of pin1 and cypA during tumor formation may be determined by their cellular location.
We examined levels of cypA and pin1 expression through the cell cycle and, in agreement with a previous report (Shen et al., 1998) , we found that levels are not altered in CML cells through the cell cycle or up to 24 h after treatment with paclitaxel or PBOX-6. However, analyses of pin1 and cypA localization after disruption of the microtubule network revealed that they undergo a dramatic redistribution from the nucleus to the cytosol and the periphery of the cell. The observed subcellular redistribution of cypA and pin1, which occurs in response to microtubule polymerization and depolymerization, may have important implications for PPIase function in tumor cells. We could not detect a nuclear localization signal or a nuclear export signal on pin1 or cypA using the PredictNLS (http://cubic.bioc.columbia.edu/ predictNLS/) and NetNES (http://www.cbs.dtu.dk/services/ NetNES/) servers. Furthermore, leptomycin B, an inhibitor of the nuclear export receptor CRM1, did not prevent the nucleocytoplasmic distribution of cypA or pin1 (data not shown).
We have shown previously that activation of the JNK MAP kinase is essential for cell death induced by PBOX-6 in K562 cells (Mc Gee et al., 2002 . In this study, we show that inhibition of JNK activity blocks the subcellular redistribution of cypA and pin1 induced by PBOX-6 in K562 cells. We also have reported previously that a trypsin-like serine protease inhibitor, TLCK, blocks cell death induced by PBOX-6 in K562 cells, whereas a chymotrypsin-like serine protease inhibitor, TPCK, does not (McGrath et al., 2006) . Consistently, in this study we show that TLCK blocks the subcellular redistribution of cypA and pin1 induced by PBOX-6 in K562 cells, whereas TPCK does not. The nucleocytoplasmic redistribution of cypA and pin1 in hematopoietic cells may lead to altered cellular function and may be an integral part of the signaling cascade initiated by microtubule-disrupting agents, such as PBOX-6.
Structural changes during mitosis effect the location and function of important regulatory proteins. We found that the cellular redistribution of cypA and pin1 correlates with the chromatin condensation during mitosis, suggesting that altered location of cypA and pin1 may correlate with breakdown of the nuclear membrane. Measurement of mitotic index, using phosphohistone H3 staining, revealed that 3% of an asynchronous cell population are undergoing early mitosis (data not shown), which correlates with the proportion of untreated cells containing cytosolic cypA and pin1. The proportion of CML cells containing cytoplasmic cypA and pin1 increased in a dose-and time-dependent manner after treatment with PBOX-6 or paclitaxel and correlates with increased G 2 /M arrest. Furthermore, the cellular redistribution of cypA and pin1 precedes apoptosis, suggesting it is not the result of bystander alterations associated with the subsequent cell death. These findings are consistent with protein redistribution during mitotic nuclear membrane breakdown as previously reported for the inner nuclear membrane proteins: lamin B receptor and lamina-associated proteins 1 and 2 (Yang et al., 1997; Ellenberg et al., 1999) . Breakdown of the nuclear membrane during mitosis may allow access to important PPIase substrates and/or facilitate transport of target molecules within the cell. This is consistent with a report that cypA peptidyl-prolyl isomerase activity promotes nuclear export of the zinc finger-containing protein, ZPR1, in yeast cells (Ansari et al., 2002) . In addition, cypA binds and regulates the cytoplasmic nonreceptor tyrosine kinase, Itk, in Jurkat cells through its isomerase activity, thereby acting as a molecular switch in the regulation of Itk activity; however, it is not known how this alteration is initiated (Brazin et al., 2002) . Based on our observations in Jurkat cells, it is possible that cypA regulates Itk in a cell cycle-dependent manner during nuclear membrane breakdown. In support of this 6 ) were treated with either vehicle (0.1% DMSO) or paclitaxel (1 M) for 1, 2, 4, 6, and 8 h (A) or 0.01, 0.1, 0.5, and 1 M paclitaxel for 8 h (B). An aliquot of cells (200 l) was cytocentrifuged onto slides and fixed in 3% paraformaldehyde for 30 min followed by permeabilization in 0.1% Triton X-100 for 3 min. Cells were blocked in 2% BSA for 30 min and incubated with anti-cypA or antipin1 antibody (1:100) for 1 h before washing in PBS. Cells were incubated with Alexa Fluor 594 and Alexa Fluor 488 (1:200) to detect cypA and pin1, respectively. Nuclei were stained blue with DAPI (1 g/ml) and viewed by fluorescent microscopy. Cells containing cytoplasmic cypA and pin1 were quantified by counting three fields of view with approximately 100 cells/view. C and D, cells were harvested by centrifugation and fixed in 70% ethanol overnight at 4°C. Cells were washed in PBS followed by the addition of RNase A (0.5 mg/ml) and propidium iodide (200 M), and samples were incubated at 37°C for 30 min. The percentage of cells in G 2 /M was determined by flow cytometry.
hypothesis, pin1 has been shown to interact with the antiapoptotic Bcl-2 protein located at the mitochondrion during M phase arrest induced by paclitaxel, where it is thought to alter its conformation and function, thereby implicating a role in the regulation of cell death (Pathan et al., 2001) . The subcellular redistribution of PPIase after microtubule disruption may initiate downstream signals that connect to a cell death pathway.
Overall, this report highlights a potential role of cypA and pin1 in hematological malignancies, such as CML. Although cypA and pin1 are located in the cytosol of most solid tumor cells, our finding of a nuclear location in leukemia and lymphoma cells implies distinct protein function in solid and diffuse tumors; however, additional work is required to understand their precise function and mechanism of action. Our results suggest that in hematopoietic cells, cypA and pin1 may play a role in protein transport during cell division. Microtubule modifications leading to altered localization of cypA and pin1 may result in loss or gain of function. The identification of additional PPIase substrates will provide valuable information to help decipher their precise cellular function.
The critical role of microtubules during cell division makes them attractive therapeutic targets, particularly in rapidly dividing tumors cells such as leukemia and lymphomas. Altered cypA and pin1 function may be an important molecular mechanism by which microtubule-targeting agents exert their effects. Pin1 has already been highlighted as a potential therapeutic target in cancer therapy. Our results suggest that in addition to pin1, cypA may also represent an attractive therapeutic target in hematopoietic malignancies.
